
Solventum Corporation (SOLV) Stock Forecast & Price Target
Solventum Corporation (SOLV) Analyst Ratings
Bulls say
Solventum is in a strong position to capitalize on the growing healthcare industry, with a diverse portfolio of products that address a variety of customer and patient needs. Its focus on material science, data science, and digital capabilities gives it a competitive edge in the market and potential for future growth. The company's recent 1Q26 results were strong, with organic growth and higher margins, and the 2028 financial targets show promise for continued success. The potential for offensive M&A and divestitures in the future also indicates strategic planning and a drive towards consistent growth.
Bears say
Solventum is facing significant challenges in its MedSurg segment, which saw a decline in operating margins of 470 basis points year-over-year. The company's tariff impact is expected to continue into FY26, potentially hindering the company's financial performance. Additionally, the company is facing increased competition and risks such as higher costs and lower growth in key markets, which could negatively impact its ability to generate profits and drive shareholder value.
This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.
Solventum Corporation (SOLV) Analyst Forecast & Price Prediction
Start investing in Solventum Corporation (SOLV)
Order type
Buy in
Order amount
Est. shares
0 shares